BAX Baxter International Inc

Price (delayed)

$85.96

Market cap

$43.04B

P/E Ratio

35.52

Dividend/share

$1.09

EPS

$2.42

Enterprise value

$46.22B

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating ...

Highlights
The EPS has grown by 35% YoY and by 9% from the previous quarter
BAX's net income is up by 33% year-on-year and by 8% since the previous quarter
The quick ratio is down by 17% year-on-year
The gross margin is down by 3.4% year-on-year

Key stats

What are the main financial stats of BAX
Market
Shares outstanding
500.69M
Market cap
$43.04B
Enterprise value
$46.22B
Valuations
Price to earnings (P/E)
35.52
Price to book (P/B)
4.9
Price to sales (P/S)
3.45
EV/EBIT
29.82
EV/EBITDA
19.2
EV/Sales
3.71
Earnings
Revenue
$12.45B
EBIT
$1.55B
EBITDA
$2.41B
Free cash flow
$1.5B
Per share
EPS
$2.42
Free cash flow per share
$2.99
Book value per share
$17.54
Revenue per share
$24.9
TBVPS
$29.67
Balance sheet
Total assets
$19.81B
Total liabilities
$10.99B
Debt
$6.44B
Equity
$8.77B
Working capital
$4.73B
Liquidity
Debt to equity
0.73
Current ratio
2.37
Quick ratio
1.55
Net debt/EBITDA
1.32
Margins
EBITDA margin
19.3%
Gross margin
39.3%
Net margin
9.8%
Operating margin
13.9%
Efficiency
Return on assets
6.1%
Return on equity
14.1%
Return on invested capital
10.6%
Return on capital employed
9.5%
Return on sales
12.4%
Dividend
Dividend yield
1.26%
DPS
$1.09
Payout ratio
44.8%

BAX stock price

How has the Baxter International stock price performed over time
Intraday
-0.37%
1 week
0.26%
1 month
0.48%
1 year
8.11%
YTD
0.14%
QTD
0.14%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$12.45B
Gross profit
$4.89B
Operating income
$1.73B
Net income
$1.21B
Gross margin
39.3%
Net margin
9.8%
BAX's net income is up by 33% year-on-year and by 8% since the previous quarter
Baxter International's net margin has increased by 24% YoY and by 7% from the previous quarter
The revenue is up by 8% year-on-year and by 2.1% since the previous quarter
The operating margin has decreased by 8% YoY

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
P/E
35.52
P/B
4.9
P/S
3.45
EV/EBIT
29.82
EV/EBITDA
19.2
EV/Sales
3.71
The EPS has grown by 35% YoY and by 9% from the previous quarter
BAX's P/E is 5% below its 5-year quarterly average of 37.7 and 2.6% below its last 4 quarters average of 36.6
BAX's P/B is 7% above its 5-year quarterly average of 4.6 and 2.5% above its last 4 quarters average of 4.8
The company's equity rose by 3.2% QoQ and by 2.4% YoY
The revenue is up by 8% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is Baxter International business performance
The ROIC has soared by 54% YoY and by 3.9% from the previous quarter
The ROS has grown by 48% YoY
The ROA has grown by 30% YoY and by 7% from the previous quarter
The company's return on equity rose by 25% YoY and by 8% QoQ

Dividends

What is BAX's dividend history
DPS
$1.09
Dividend yield
1.26%
Payout ratio
44.8%
Recent dividends

Financial health

How did Baxter International financials performed over time
The total assets is 80% more than the total liabilities
The quick ratio is down by 17% year-on-year
The current ratio fell by 10% YoY
Baxter International's debt is 27% less than its equity
The debt to equity has declined by 10% year-on-year and by 6% since the previous quarter
Baxter International's debt has decreased by 8% YoY and by 3% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.